CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −240 | $108.93 | $26K | 205,695 |
| 2024-11-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 26,638 | ||
| 2024-10-28 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise | +1,585 | $5.35 | $8K | 202,231 |
| 2024-10-28 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise | +3,464 | $20.93 | $73K | 205,695 |
| 2024-10-28 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) | −1,585 | 77,026 | ||
| 2024-10-28 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) | −3,464 | 89,876 | ||
| 2024-10-25 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise | +19,108 | $20.93 | $400K | 109,491 |
| 2024-10-25 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) | −19,108 | 125,892 | ||
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 98,383 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 106,383 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +12,000 | $5.35 | $64K | 118,383 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +14,000 | $5.35 | $75K | 132,383 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −36,114 | $115.26 | $4.2M | 96,269 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −5,886 | $116.19 | $684K | 90,383 |
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 312,827 | ||
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 304,827 | ||
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −12,000 | 292,827 | ||
| 2024-10-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,000 | 278,827 | ||
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −310 | $107.27 | $33K | 141,820 |
| 2024-10-07 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −887 | $108.72 | $96K | 140,933 |
Page 19 of 39 · 764 trades